In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy.
This activity is certified for CME/CNE/CPE credit. To participate and earn
credit, visit us at https://www.impactedu.net/gi-cancer-management/.
Podden och tillhörande omslagsbild på den här sidan tillhör
IMPACT. Innehållet i podden är skapat av IMPACT och inte av,
eller tillsammans med, Poddtoppen.
